These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size. Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479 [TBL] [Abstract][Full Text] [Related]
4. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era. King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755 [TBL] [Abstract][Full Text] [Related]
5. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Binkley MS; Rauf MS; Milgrom SA; Pinnix CC; Tsang R; Dickinson M; Ng AK; Roberts KB; Gao S; Balogh A; Ricardi U; Levis M; Casulo C; Stolten M; Specht L; Plastaras JP; Wright C; Kelsey CR; Brady JL; Mikhaeel NG; Hoppe BS; Terezakis SA; Picardi M; Della Pepa R; Kirova Y; Akhtar S; Maghfoor I; Koenig JL; Jackson C; Song E; Sehgal S; Advani RH; Natkunam Y; Constine LS; Eich HT; Wirth A; Hoppe RT Blood; 2020 Jun; 135(26):2365-2374. PubMed ID: 32211877 [TBL] [Abstract][Full Text] [Related]
6. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients. Dann EJ; Bairey O; Bar-Shalom R; Mashiach T; Barzilai E; Kornberg A; Akria L; Tadmor T; Filanovsky K; Abadi U; Kagna O; Ruchlemer R; Abdah-Bortnyak R; Goldschmidt N; Epelbaum R; Horowitz NA; Lavie D; Ben-Yehuda D; Shpilberg O; Paltiel O Br J Haematol; 2017 Sep; 178(5):709-718. PubMed ID: 28589704 [TBL] [Abstract][Full Text] [Related]
7. A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03). Wirth A; Prince HM; Roos D; Gibson J; O'Brien P; Zannino D; Khodr B; Stone JM; Davis S; Hertzberg M Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1158-1166. PubMed ID: 30553941 [TBL] [Abstract][Full Text] [Related]
8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
9. Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group. Rosenbrock J; Kaul H; Oertel M; Celik E; Linde P; Fan J; Eichenauer DA; Bröckelmann PJ; von Tresckow B; Kobe C; Dietlein M; Fuchs M; Borchmann P; Eich HT; Baues C Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38631539 [TBL] [Abstract][Full Text] [Related]
11. Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up. Chen RC; Chin MS; Ng AK; Feng Y; Neuberg D; Silver B; Pinkus GS; Stevenson MA; Mauch PM J Clin Oncol; 2010 Jan; 28(1):136-41. PubMed ID: 19933914 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. Eichenauer DA; Plütschow A; Fuchs M; von Tresckow B; Böll B; Behringer K; Diehl V; Eich HT; Borchmann P; Engert A J Clin Oncol; 2015 Sep; 33(26):2857-62. PubMed ID: 26240235 [TBL] [Abstract][Full Text] [Related]
13. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience. Harrington KJ; Michalaki VJ; Vini L; Nutting CM; Syrigos KN; A'hern R; Harmer CL Br J Radiol; 2005 May; 78(929):405-10. PubMed ID: 15845932 [TBL] [Abstract][Full Text] [Related]
14. Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials. Reinartz G; Molavi Tabrizi C; Liersch R; Ullerich H; Hering D; Willborn K; Schultze J; Micke O; Ruebe C; Fischbach W; Bentz M; Daum S; Pott C; Tiemann M; Moeller P; Neubauer A; Wilhelm M; Lenz G; Berdel WE; Willich N; Eich HT Oncologist; 2020 May; 25(5):e816-e832. PubMed ID: 32219909 [TBL] [Abstract][Full Text] [Related]
15. The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease. Wendland MM; Asch JD; Pulsipher MA; Thomson JW; Shrieve DC; Gaffney DK Am J Clin Oncol; 2006 Apr; 29(2):189-95. PubMed ID: 16601441 [TBL] [Abstract][Full Text] [Related]